Anmol Goyal
Cleveland Clinic(US)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, CAR-T cell therapy research, Acute Myeloid Leukemia Research, Cancer Immunotherapy and Biomarkers, Chronic Myeloid Leukemia Treatments
Most-Cited Works
- → Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma(2023)32 cited
- → Real-World Experience with Teclistamab for Relapsed/Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium(2025)10 cited
- → Bendamustine is a safe and effective lymphodepletion agent for axicabtagene ciloleucel in patients with refractory or relapsed large B-cell lymphoma(2024)10 cited
- → Adverse effects of aminoglycosides in children with drug resistant tuberculosis(2018)7 cited
- → Infantile Psoas Abscess(2013)7 cited
- Second-line treatment with CAR T-cell therapy for large B-cell lymphoma.(2023)
- → Second-Line Chimeric Antigen Receptor T Cell Therapy (CAR-T) As Standard of Care for Relapsed-Refractory Large B-Cell Lymphoma (LBCL)(2023)4 cited
- → Impact of Obesity on Efficacy, Safety, and Expansion Kinetics of Chimeric Antigen Receptor-T (CAR T) Therapy in Patients with Relapsed or Refractory Large B Cell Lymphoma (LBCL)(2023)2 cited
- → Analgesia to acidosis: metabolic acidosis due to chronic acetaminophen (paracetamol) use(2024)2 cited
- → Lisocabtagene maraleucel for treatment of relapsed and refractory primary mediastinal large B‐cell lymphoma in an adolescent patient(2024)2 cited